Artwork

Вміст надано Southern Alberta Council on Public Affairs (SACPA). Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Southern Alberta Council on Public Affairs (SACPA) або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Player FM - додаток Podcast
Переходьте в офлайн за допомогою програми Player FM !

Medical cannabis against COVID-19 - from research to clinical use

1:01:45
 
Поширити
 

Manage episode 308699878 series 3018052
Вміст надано Southern Alberta Council on Public Affairs (SACPA). Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Southern Alberta Council on Public Affairs (SACPA) або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Studies finds that enzymes in cannabis may be able to treat COVID-19. Researchers at the University of Lethbridge recently released results from a study that shows the benefits of CBD as an aid in blocking the cells that enter the body from the novel coronavirus. The study is a partnership among the university, Pathway, which works to develop cannabis therapies to treat specific diseases, and cannabinoid-based oral health company Swysh Inc. The researchers at U of L conducted a study using artificial 3D models of oral, airway and intestinal tissues coupled with a limited sample of high CBD Cannabis sativa extracts, modulate ACE2 gene expression and ACE2 protein levels. The results indicated hemp extracts high in CBD may help block proteins that provide a “gateway” for COVID-19 to enter host cells. The speaker will elaborate. Speaker: Dr. Olga Kovalchuk Dr. Kovalchuk received her B. Med. (Honors, 1992) and M.D. (Stomatology, 1994) degrees at the Ivano-Frankivsk National Medical University in Ukraine. In 1994 she began a career at the Medical University and the Chernobyl Research Centre studying consequences of the Chernobyl accident, and in 1998 received a PhD (Medical Genetics). Dr. Kovalchuk conducted extensive postdoctoral training at the Friedrich Miescher Institute and in Novartis/Syngenta (Switzerland). Currently Dr. Olga Kovalchuk is a Professor and a Board of Governors’ Research Chair in Epigenetics of Health and Diseases at the University of Lethbridge, Alberta. In 2008-2018 she held the Canadian Institutes for Health Research – Institute of Gender and Health (CIHR-IGH) Chairs in Gender and Health, and in Gender, Work and Health. Dr. Kovalchuk is an internationally-renowned leader and an expert in epigenetics and epigenomics of health and disease, environmental epigenomics, and radiation biology and oncology. She is studying mechanisms of disease, epigenetics, novel precision medicine approaches and novel cannabis-based disease therapies. She is a co-founder of the PathwayRx, a research and development medical cannabis company developing personalized approaches for cannabis-based treatment of cancer and age-related diseases. Date and time: Thursday, May 28, 2020 at 10 am YouTube Live link https://youtu.be/sj60GmfFht4 In order to ask questions of our speaker in the chat feature of YouTube, you must have a YouTube account and be signed in. Please do so well ahead of the scheduled start time, so you’ll be ready. Go the YouTube Live link provided in this session flyer and on the top right of your browser click the “sign in” button. If you have Google or Gmail accounts, they can be used to sign in. If you don’t, click “Create Account” and follow along. Once you are signed in, you can return to the live stream and use the chat feature to ask your questions of the speaker. Remember you can only participate in the chat feature while we are livestreaming. Link to SACPA’s YouTube Channel: https://www.youtube.com/channel/UCFUQ5mUHv1gfmMFVr8d9dNA
  continue reading

1204 епізодів

Artwork
iconПоширити
 
Manage episode 308699878 series 3018052
Вміст надано Southern Alberta Council on Public Affairs (SACPA). Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Southern Alberta Council on Public Affairs (SACPA) або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Studies finds that enzymes in cannabis may be able to treat COVID-19. Researchers at the University of Lethbridge recently released results from a study that shows the benefits of CBD as an aid in blocking the cells that enter the body from the novel coronavirus. The study is a partnership among the university, Pathway, which works to develop cannabis therapies to treat specific diseases, and cannabinoid-based oral health company Swysh Inc. The researchers at U of L conducted a study using artificial 3D models of oral, airway and intestinal tissues coupled with a limited sample of high CBD Cannabis sativa extracts, modulate ACE2 gene expression and ACE2 protein levels. The results indicated hemp extracts high in CBD may help block proteins that provide a “gateway” for COVID-19 to enter host cells. The speaker will elaborate. Speaker: Dr. Olga Kovalchuk Dr. Kovalchuk received her B. Med. (Honors, 1992) and M.D. (Stomatology, 1994) degrees at the Ivano-Frankivsk National Medical University in Ukraine. In 1994 she began a career at the Medical University and the Chernobyl Research Centre studying consequences of the Chernobyl accident, and in 1998 received a PhD (Medical Genetics). Dr. Kovalchuk conducted extensive postdoctoral training at the Friedrich Miescher Institute and in Novartis/Syngenta (Switzerland). Currently Dr. Olga Kovalchuk is a Professor and a Board of Governors’ Research Chair in Epigenetics of Health and Diseases at the University of Lethbridge, Alberta. In 2008-2018 she held the Canadian Institutes for Health Research – Institute of Gender and Health (CIHR-IGH) Chairs in Gender and Health, and in Gender, Work and Health. Dr. Kovalchuk is an internationally-renowned leader and an expert in epigenetics and epigenomics of health and disease, environmental epigenomics, and radiation biology and oncology. She is studying mechanisms of disease, epigenetics, novel precision medicine approaches and novel cannabis-based disease therapies. She is a co-founder of the PathwayRx, a research and development medical cannabis company developing personalized approaches for cannabis-based treatment of cancer and age-related diseases. Date and time: Thursday, May 28, 2020 at 10 am YouTube Live link https://youtu.be/sj60GmfFht4 In order to ask questions of our speaker in the chat feature of YouTube, you must have a YouTube account and be signed in. Please do so well ahead of the scheduled start time, so you’ll be ready. Go the YouTube Live link provided in this session flyer and on the top right of your browser click the “sign in” button. If you have Google or Gmail accounts, they can be used to sign in. If you don’t, click “Create Account” and follow along. Once you are signed in, you can return to the live stream and use the chat feature to ask your questions of the speaker. Remember you can only participate in the chat feature while we are livestreaming. Link to SACPA’s YouTube Channel: https://www.youtube.com/channel/UCFUQ5mUHv1gfmMFVr8d9dNA
  continue reading

1204 епізодів

Усі епізоди

×
 
Loading …

Ласкаво просимо до Player FM!

Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.

 

Короткий довідник

Слухайте це шоу, досліджуючи
Відтворити